Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Scynexis (SCYX) Research & Development (2016 - 2025)

Scynexis (SCYX) has disclosed Research & Development for 13 consecutive years, with $4.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Research & Development rose 5.38% year-over-year to $4.5 million, compared with a TTM value of $22.3 million through Dec 2025, down 15.62%, and an annual FY2025 reading of $22.3 million, down 15.62% over the prior year.
  • Research & Development was $4.5 million for Q4 2025 at Scynexis, down from $5.5 million in the prior quarter.
  • Across five years, Research & Development topped out at $10.6 million in Q4 2023 and bottomed at $4.3 million in Q4 2024.
  • Average Research & Development over 5 years is $6.5 million, with a median of $6.8 million recorded in 2023.
  • The sharpest move saw Research & Development soared 50.63% in 2022, then crashed 59.26% in 2024.
  • Year by year, Research & Development stood at $7.7 million in 2021, then increased by 2.07% to $7.8 million in 2022, then skyrocketed by 34.87% to $10.6 million in 2023, then crashed by 59.26% to $4.3 million in 2024, then grew by 5.38% to $4.5 million in 2025.
  • Business Quant data shows Research & Development for SCYX at $4.5 million in Q4 2025, $5.5 million in Q3 2025, and $7.1 million in Q2 2025.